-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904. Outcomes Research—Non-Malignant Conditions: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 12, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Diego Adrianzen Herrera, MD1, Pamela L Lutsey, PhD, MPH2*, Katherine Giorgio, BS2* and Neil A. Zakai, MD, MSc3

1Division of Hematology and Oncology, Larner College of Medicine at the University of Vermont, Burlington, VT
2School of Public Health, University of Minnesota, Minneapolis, MN
3Fletcher Allen Health Care, University of Vermont, Burlington, VT

Christian von Heymann, MD, PhD1*, Martin Unverdorben, MD, PhD2*, Paolo Colonna, MD3*, Amparo Santamaria Ortiz, MD, PhD4*, Manish Saxena, MBBS5*, Thomas Vanassche, MD6*, Jeffrey I. Weitz, MD, FRCPC7, Robert Wilkins, MBChB8* and Cathy Chen, MD2*

1Vivantes Klinikum im Friedrichshain, Berlin, Germany
2Global Medical Affairs, Daiichi Sankyo, Basking Ridge, NJ
3Polyclinic Hospital of Bari, Bari, Italy
4University Hospitals of Vinalopo and Torrevieja, Alicante, Spain
5Barts Health NHS Trust, NIHR CV BRC, London, United Kingdom
6UZ Leuven, Leuven, Belgium
7Department of Medicine, Hematology and Thromboembolism, McMaster University, Hamilton, Canada
8QPS Consulting, LLC, Ashburn, VA

Rodolfo D Cançado1, Fernando Ferreira Costa, MD, PhD2, Clarisse Lobo, MD, PhD3, Celina Borges Migliavaca4*, Maicon Falavigna4*, Homero C. R. Souza Filho5*, Carolina Tosin Bueno, PhD6* and Ana Cristina Silva Pinto, MD, PhD7*

1Department of Hematology/Oncology, Santa Casa Medical School, São Paulo, Brazil
2School of Medical Sciences, University of Campinas, Campinas, SP, Brazil
3Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti (Hemorio), Rio de Janeiro, Brazil
4HTAnalyze Consultoria e Treinamento, Porto Alegre, Brazil
5Department of Hematology–Oncology, Novartis Oncology, São Paulo, Brazil
6Novartis Oncology, Sao Paulo, Brazil
7Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Brazil, Sao Paulo, Brazil

Ifeyinwa Osunkwo, MD, MPH1, Biree Andemariam, MD2, Caterina P Minniti, MD3, Fuad El Rassi, MD4, Erfan Nur, MD, PhD5, Alecia C Nero, MD6*, Raffaella Colombatti, MD7, Mariane de Montalembert, MD, PhD8, Miguel R Abboud, MD9, Jean-Benoît Arlet, MD10*, Suman Jain, MD11*, Wasil Jastaniah, MD12*, Marimilia Pita, MD13*, Beverley Francis-Gibson14*, Cassandra Trimnell, BA15*, Laurie DeBonnett, MD16*, Tom Bailey, MSci17*, Olivera Rajkovic-Hooley, PhD17*, Baba PD Inusa, MD, MBBS18 and John James, MSc19*

1Sickle Cell Disease Enterprise at the Levine Cancer Institute/, Atrium Health - Wake Forest School of Medicine, Charlotte, NC
2New England Sickle Cell Institute at the University of Connecticut, Farmington, CT
3Albert Einstein College of Medicine, New York, NY
4Emory University School of Medicine and Georgia Comprehensive Sickle Cell Center at Grady Health System, Atlanta, GA
5Amsterdam University Medical Centers, Academic Medical Center, Amsterdam, Netherlands
6University of Texas Southwestern Medical Center, Dallas, TX
7Azienda Ospedale-Università di Padova, Padova, Italy
8Hôpital Universitaire Necker-Enfants Malades, Paris, France
9American University of Beirut Medical Center, Beirut, Lebanon
10Hôpital Européen Georges-Pompidou, Paris, France
11Thalassemia and Sickle Cell Society, Hyderabad, India
12Umm Al-Qura University, Mecca, Saudi Arabia
13Laureate University-UAM, Pediatric-Hematology, Hospital Samaritano, São Paulo, Brazil
14Sickle Cell Disease Association of America, Baltimore, MD
15Sickle Cell 101, San Jose, CA
16Novartis Pharmaceuticals Corporation, East Hanover, NJ
17Adelphi Real World, Bollington, United Kingdom
18Evelina Children's Hospital and Guy’s and St Thomas’ Hospital, London, United Kingdom
19Sickle Cell Society, London, United Kingdom

Kristen M. Sanfilippo, MD1,2, Suhong Luo, MS3,4* and Tzu-Fei Wang, MD5

1Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
2St. Louis Veterans Affairs Medical Center Research Service, Saint Louis, MO
3St. Louis Veterans Affairs Medical Center Research Service, Saint Louis
4Washington University in St. Louis School of Medicine, St. Louis, MO
5Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada

Katharine Batt, MD, MSc1, Bob G Schultz2*, Jorge Caicedo, MD3*, Christopher S Hollenbeak, PhD4*, Neha Agrawal, BA, MA5*, Sagnik Chatterjee, BA, MA5*, Megha Dayma, BSc, MSc5* and Michael Bullano, PharmD, MS3*

1Sprouts Consulting Ltd., Raleigh, NC
2Takeda Pharmaceuticals U.S.A., Inc., Chicago, IL
3Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA
4Department of Health Policy and Administration, The Pennsylvania State University, College of Health and Human Development, University Park, PA
5Complete HEOR Solutions, New Wales, PA

Tien-Chan Hsieh, M.D.1,2, Guangchen Zou, M.D.1,2*, Gin Yi Lee, M.D.1,2*, Pramuditha Rajapakse, M.D.1,2* and Yee Hui Yeo, M.D., M.Sc.3*

1Medicine, Danbury Hospital, Danbury, CT
2Medicine, The University of Vermont, Burlington, VT
3Medicine, Cedars-Sinai Medical Center, Los Angeles, CA

Anirudh Veludhandi, BS1*, Tami D John, MD2*, Nitya Bakshi, MBBS, MS3,4, Staci D. Arnold, MD, MBA, MPH5, Monica Bhatia, MD6,7*, Peter A. Lane, MD8, Lillian Meacham, MD9,10*, Kirshma Khemani, MD11,12*, Sonali Chaudhury, MD13*, Festus Olusola Olowoselu14*, Kimberly A. Kasow, DO15*, Matthew Hsieh, MD16, Allistair Abraham, MD17, Gregory M.T. Guilcher, MD18 and Lakshmanan Krishnamurti, MD11,19,20

1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta - Egleston, Atlanta, GA
2Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
3Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
4Department of Pediatrics/Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA
5Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, GA
6Columbia University, New York, NY
7Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, NY
8Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA
9Pediatric Endocrinology, Emory University, Atlanta, GA
10Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
11Department of Pediatrics, Division of Hematology/Oncology/BMT, Emory University School of Medicine, Atlanta, GA
12Children's Healthcare of Atlanta, Atlanta, GA
13Lurie Children's Hospital of Chicago, Chicago, IL
14Department of Haematology and Blood Transfusion, Faculty of Clinical Science, College of Medicine, University of Lagos, Nigeria., Lagos, Nigeria
15Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
16Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
17Children's National Hospital, Vienna, VA
18Alberta Children's Hospital, Calgary, AB, CAN
19Emory University, Atlanta, GA
20Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University, Atlanta, GA

Alex Cockerham, MSc1*, Amanda Wilson2*, Andrew Frick3* and Pronabesh Dasmahapatra2

1Sanofi, Brookline, MA
2Sanofi, Cambridge, MA
3Trio Health, San Diego, CA

Vania Munaretto, MD1*, Giulia Reggiani2*, Chiara Munerol, MD3*, Elizabeth Maran3*, Marina Perdibon3*, Anna Chiara Frigo3*, Alessandra Biffi, MD4*, Laura Sainati, MD5* and Raffaella Colombatti, MD6

1Clinic of Pediatric Hematology Oncology, Department of Woman's and Child's Health, Azienda Ospedaliera-Università di Padova, Padova, Italy
2Clinic of Pediatric Hematology Oncology, Department of Woman’s and Child’s Health, Azienda Ospedale – Università di Padova, Padua, Italy, Padova, Italy
3Azienda Ospedaliera-Università di Padova, Padova, Italy
4Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Padova, Padova, AL, Italy
5Azienda Ospedaliera Universitaria, Padova, Italy
6UOC Pediatric Hematology Oncology, University of Padova, Padova, Italy

Divyaswathi Citla Sridhar, MD1, Robert F. Sidonio Jr., MD, MSc2, Michael Silvey, DO3, Dunlei Cheng4* and Sanjay Ahuja, MD5

1Arkansas Children's hospital, University of Arkansas for Medical Sciences, Little Rock, AR
2Hemophilia of Georgia Center for Bleeding and Clotting Disorders, Emory University, Decatur, GA
3Childrens Mercy Hospital, Kansas City, MO
4American Thrombosis and Hemostasis Network, Rochester, NY
5Rainbow Babies and Children's Hospital, Cleveland, OH

Hayley Merkeley, MD, MSc1,2, Marlee McGuire, PhD3*, Lillian Ding, MSc3*, Heather McCartney, BSN, RN4*, Ali Amid, MD1,4, Caron Strahlendorf, MBBCh, DHealth1,4*, Nina Sandhu, BSN, RN2*, Dimitrios Vergidis, MD2* and Maureen O'Donnell, MD, MSc1,3,4*

1University of British Columbia, Vancouver, BC, Canada
2St. Paul's Hospital, Vancouver, BC, Canada
3Provincial Health Services Authority, Vancouver, BC, Canada
4BC Children's Hospital, Vancouver, BC, Canada

Daniel K. Reef, MD, BA1, Alyssa De Castro, PharmD2*, Jennat Mustafa, PA-C2*, Fariha Khatun, PA-C2*, Amanda Lombardo, PA-C, BS, MS2*, Latoya Townsend Nugent, NP2*, Kira Gritsman, MD, PhD3,4,5, Mendel Goldfinger, MD4,6, Noah Kornblum, MD2*, Aditi Shastri, MD5,7, Ioannis Mantzaris, MD, MS5,7, Lizamarie Bachier-Rodriguez, MD2,6*, Amit Verma, MD8, Ira Braunschweig, MD4 and R. Alejandro Sica, MD9

1Department of Internal Medicine, Montefiore Medical Center, New York, NY
2Department of Oncology, Montefiore Medical Center, Bronx, NY
3Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
4Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
5Division of Hematologic Malignancies, Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
6Albert Einstein College of Medicine, Bronx
7Department of Medicine, Albert Einstein College of Medicine, Bronx, NY
8Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
9Department of Medicine (Oncology), Montefiore Medical Center, Bronx, NY

Olufunke Y. Martin, MD1, Deepika S. Darbari, MD2, Stefanie Margulies, MS3*, Robert Sheppard Nickel, MD, MSc4, Alexis Leonard, MD5,6, Barbara Speller-Brown, DNP, CPNP-BC7*, Brenda Martin, MSN, CPNP3*, Jennifer Webb, MD4,8, Suvankar Majumdar, MBCHB3,9, Matthew Sharron, MD3* and Andrew D. Campbell, MD9,10

1Department of Hematology/Oncology, Children's National Hospital, Washington, DC
2Pediatrics, The George Washington University School of Medicine, Washington, DC
3Children's National Hospital, Washington, DC
4George Washington University School of Medicine and Health Sciences, Washington, DC
5Center for Cancer and Blood Disorders, Children's National Health System, Chevy Chase, MD
6Cellular and Molecular Therapeutics Branch, NHLBI, National Institutes of Health, Bethesda, MD
7Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC
8Children's National Health System, Washington, DC
9The George Washington University School of Medicine and Health Sciences, Washington, DC
10Center for Cancer and Blood Disorders, Childrens National Hospital, Washington, DC

Idoroenyi Amanam, MD1, Janny M. Yao, PharmD2*, Alfredo Puing, MD3*, Ni-Chun Tsai, MS4*, Diana Samuels, PharmD2*, Dat Ngo, PharmD2*, Stephanie Ho, PharmD2*, Haris Ali, MD1, Ahmed Aribi, MD1, Shukaib Arslan, MD1, Andrew S. Artz, MD, MS5, Myo Htut6, Paul Koller, MD1, Amandeep Salhotra, MD1, Karamjeet S. Sandhu, MD 1, Liana Nikolaenko, MD1, Anna B Pawlowska, MD7, Geoffrey Shouse, PhD1, Anthony S. Stein, MD1, Guido Marcucci, MD1, Stephen J Forman, MD1, Ryotaro Nakamura, MD1, Sanjeet S Dadwal, MD3 and Monzr M. Al Malki, MD1

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Pharmacy, City of Hope National Medical Center, Duarte, CA
3Division of Infectious Disease, City of Hope National Medical Center, Duarte, CA
4Department of Computational and Quantitative Medicine-BRI, City of Hope National Medical Center, Duarte, CA
5Department of Hematology/HCT, City of Hope, Duarte, CA
6Comprehensive Cancer Center, City of Hope National Medical Center, Duarte, CA
7Department of Pediatrics, City of Hope National Medical Center, Duarte, CA

Sherif M. Badawy, MD1,2, Lisa DiMartino, PhD, MPH3*, Donald Brambilla, PhD4, Ana Baumann, PhD5*, Ebony Burns, MHA6*, Theresa Demartino6*, Sara Jacobs7*, Hamda Khan, MA8*, Lisa Klesges, PhD9*, Abdullah Kutlar, MD10,11, Chinonyelum Nwosu12*, Nirmish Shah, MD6* and Jane S Hankins, MD, MS8,13

1Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
2Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert Lurie Children's Hospital of Chicago, Chicago, IL
3Division of Social Policy, Health and Economics Research, RTI International, Durham, NC
4RTI International, Rockville, MD
5Washington University School of Medicine, St Louis, MO
6Duke University Medical Center, Durham, NC
7RTI International, Chicago
8Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
9Department of Surgery, Washington University in St. Louis, St Louis, MO
10Augusta University, Augusta, GA
11Sickle Cell Center, Medical College of Georgia, Augusta University, Augusta, GA
12St.Jude Children's Research Hospital, Memphis
13Methodist Comprehensive Sickle Cell Center, Memphis, TN

Deirdra R Terrell, PhD1, Rachel Ann Kelley, BS2*, Amanda J Llaneza, MPH2*, Sara K. Vesely, PhD, MPH3, Janna Journeycake, MD, MSCS4, Mohamad O. Khawandanah, MBBS5, Marshall Mazepa, MD6*, Frank Akwaa, MD7*, Adam Cuker, MD, MS8, Shruti Chaturvedi, MBBS9, Neil A. Zakai, MD, MSc10, Ming Yeong Lim, MBBChir11, Radhika Gangaraju, MD12 and Spero Cataland, MD13

1University of Oklahoma Health Sciences Ctr, Oklahoma City, OK
2Univ of Oklahoma Health Sciences Center, Oklahoma City, OK
3Biostatistics and Epidemiology, Hudson College of Public Health, The University of Oklahoma, Oklahoma City, OK
4Jimmy Everest Center for Cancer and Blood Disorders, University of Oklahoma Health Sciences Center, Oklahoma City, OK
5Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK
6Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
7Department of Medicine, Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY
8Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
9Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
10Division of Hematology and Oncology, Larner College of Medicine at the University of Vermont, Burlington, VT
11Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT
12Division of Hematology and Oncology, University Of Alabama, Birmingham, AL
13Division of Hematology, Department of Internal Medicine, Ohio State University Medical Center, Columbus, OH

*signifies non-member of ASH